D012294Chemicals & DrugsD03.633.400.811D04.345.295.750550.994557Rifamycinsplugins:TwitterTwitterprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMolecular Genetics and Cell BiologyMedicine-GastroenterologyMedicine-General Internal Medicine21559740Pimentel M, Morales W, Chua K, Barlow G, Weitsman S, Kim G, Amichai MM, Pokkunuri V, Rook E, Mathur R, Marsh ZDigestive diseases and sciencesEffects of rifaximin treatment and retreatment in nonconstipated IBS subjects. Dig Dis Sci. 2011 Jul; 56(7):2067-72.Dig Dis Sci2011-05-11T00:00:002011Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.17567869Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical AllianceInflammatory bowel diseasesRifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13(10):1250-5.Inflamm Bowel Dis2007-10-01T00:00:002007Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.4807457Bogorad L, Mets LJ, Mullinix KP, Smith HJ, Strain GCBiochemical Society symposiumPossibilities for intracellular integration: The ribonucleic acid polymerases of chloroplasts and nuclei, and genes specifying chloroplast ribosomal proteins. Biochem Soc Symp. 1973; (38):17-41.Biochem Soc Symp1973-01-01T00:00:001973Possibilities for intracellular integration: The ribonucleic acid polymerases of chloroplasts and nuclei, and genes specifying chloroplast ribosomal proteins.0.5907360.001782995research area of0.5939690.007170985subject area forhttps://chronicdisease.uchicago.edu/Center for Chronic Disease Research and Policyhttp://chicagodiabetesresearch.org/Chicago Center for Diabetes Translation Research@ChronicDiseaseUMedicineUniversity of ChicagoHelen S.TeHelen S. Te41.78927490000000-87.601250000000002428Te, Helen S.ProfessorLaurens J.MetsLaurens J. Mets41.78927490000000-87.60125000000000311Mets, Laurens J.Associate ProfessorStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/EmeritaElbertHuangElbert Huang41.78927490000000-87.60125000000000680Huang, ElbertProfessorGene H.KimGene H. Kim41.78927490000000-87.60125000000000921Kim, Gene H.Associate Professortrue1Emeritus/EmeritaEmeritus/Emeritatrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorMedicine-Cardiology17894657Huang E, Esrailian E, Spiegel BMAlimentary pharmacology & therapeuticsThe cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Aliment Pharmacol Ther. 2007 Oct 15; 26(8):1147-61.Aliment Pharmacol Ther2007-10-15T00:00:002007The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.27655104Dong T, Aronsohn A, Gautham Reddy K, Te HSDigestive diseases and sciencesRifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci. 2016 12; 61(12):3621-3626.Dig Dis Sci2016-09-21T00:00:002016Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.